Overview

A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis

Status:
RECRUITING
Trial end date:
2026-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the intestinal flora in subjects with systemic sclerosis-related constipation and/or significant bloating and to determine safety and trends in improvements in the diversity of colonic microbiome and patient symptoms following the administration of either frozen or lyophilized PRIM-DJ2727 microbiota.
Phase:
PHASE2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston